Andreu Alibés

Author PubWeight™ 0.75^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells.	Oncotarget	2016	0.75